National Center for Advancing Translational Sciences; Notice of Meeting, 81214-81215 [2020-27547]
Download as PDF
<![CDATA[
81214
Federal Register / Vol. 85, No. 241 / Tuesday, December 15, 2020 / Notices
Contact Person: Kristen Page, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health,
6705 Rockledge Drive, Room 209–B,
Bethesda, MD 20892, (301) 827–7953,
kristen.page@nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Stimulating Access to Research in Residency
Transition Scholar.
Date: January 27, 2021.
Time: 2:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6705
Rockledge Drive, Bethesda, MD 20817
(Virtual Meeting).
Contact Person: Kristen Page, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health,
6705 Rockledge Drive, Room 209–B,
Bethesda, MD 20892, (301) 827–7953,
kristen.page@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: December 9, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–27493 Filed 12–14–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory Child
Health and Human Development
Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications/
contract proposals and the discussions
could disclose confidential trade secrets
or commercial property such as
VerDate Sep<11>2014
17:35 Dec 14, 2020
Jkt 253001
patentable material, and personal
information concerning individuals
associated with the grant applications,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Child Health and Human Development
Council.
Date: February 2, 2021.
Open: 12:30 p.m. to 05:00 p.m.
Agenda: The agenda will include opening
remarks, administrative matters, Director’s
Report, Division of Extramural Research
Report, and other business of the Council.
Place: National Institutes of Health
(Teleconference), 6710B Rockledge Dr.,
Bethesda, MD 21157.
Date: February 3, 2021.
Closed: 12:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health
(Teleconference), 6710B Rockledge Dr.,
Bethesda, MD 21157.
Contact Person: Robert Borie, Committee
Management Specialist, Eunice Kennedy
Shriver National Institute of Child Health
and Human Development, NIH, 6710B
Rockledge Drive, 2221A, Bethesda, MD
20892, 301.827.6244, robert.borie@nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the contact person listed on
this notice. The statement should include the
name, address, telephone number, and when
applicable, the business or professional
affiliation of the interested person. Any
member of the public may submit written
comments no later than 15 days after the
meeting.
Individuals will be able to view the
meeting via NIH Videocast. Select the
following link for Videocast access
instructions: https://www.nichd.nih.gov/
about/advisory/nachhd/Pages/virtualmeeting.aspx.
Information is also available on the
Institute’s/Center’s home page: https://
www.nichd.nih.gov/about/advisory/council,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: December 9, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–27470 Filed 12–14–20; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Advancing
Translational Sciences; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Center for
Advancing Translational Sciences
Advisory Council.
The meeting will be open to the
public as indicated below, viewing
virtually by WebEx. Individuals can
register to view and access the meeting
by the links below:
January 14, 2021 WebEx: https://
nih.webex.com/nih/onstage/
g.php?MTID=efd5d81157ca86678111
c546ced7a91fa.
January 15, 2021 WebEx: https://
nih.webex.com/nih/onstage/
g.php?MTID=eda63cdefa13a124
ac49e7cffdac33aac.
1. Go to ‘‘Event Status’’ on the lefthand side of page, then click ‘‘Register’’.
On the registration form, enter your
information and then click ‘‘Submit’’ to
complete the required registration.
2. You will receive a personalized
email with the live event link.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Advisory
Council.
Date: January 14–15, 2021.
Closed: January 14, 2021, 11:00 a.m. to
12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, 9th Floor, Conference
Rooms 987/989, 6701 Democracy Boulevard,
Bethesda, MD 20892 (Virtual Meeting).
Open: January 14, 2021, 1:00 p.m. to 4:00
p.m.
Agenda: Report from the Institute Director
and other staff.
Place: National Institutes of Health, One
Democracy Plaza, 9th Floor, Conference
Rooms 987/989, 6701 Democracy Boulevard,
Bethesda, MD 20892 (Virtual Meeting).
Open: January 15, 2021, 1:00 p.m. to 5:00
p.m.
Agenda: To view and discuss Clearance of
Concepts.
E:\FR\FM\15DEN1.SGM
15DEN1
Federal Register / Vol. 85, No. 241 / Tuesday, December 15, 2020 / Notices
Place: National Institutes of Health, One
Democracy Plaza, 9th Floor, Conference
Rooms 987/989, 6701 Democracy Boulevard,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Anna L. Ramsey-Ewing,
Ph.D., Executive Secretary, National Center
for Advancing Translational Sciences, One
Democracy Plaza, Room 1072, Bethesda, MD
20892, (301) 435–0809, anna.ramseyewing@
nih.gov.
Attendees and interested parties may
submit questions and comments through
written Q&A during the meeting, and for 15
days after the meeting, to
NCATSCouncilInput@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice no later than 15 days after the
meeting. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS).
Dated: December 10, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–27547 Filed 12–14–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF THE INTERIOR
Fish and Wildlife Service
[FWS–R2–ES–2020–N126;
FXES11140200000–201–FF02ENEH00]
Draft Amendment to the Environmental
Assessment/Habitat Conservation Plan
Previously Associated With the 440acre Schlumberger Property for
Concordia University, Texas
AGENCY:
Fish and Wildlife Service,
Interior.
Notice of availability; request
for public comments.
ACTION:
Concordia University has
applied to the U.S. Fish and Wildlife
Service for an amended incidental take
permit (ITP) under the Endangered
Species Act. The requested amended
ITP, if granted, would authorize
incidental take of the Jollyville Plateau
salamander, in addition to the already
existing ITP for golden-cheeked warbler.
The proposed incidental take would
result from activities associated with
otherwise lawful activities, including
construction, operation, and
maintenance of Concordia University,
that result in water quality and habitat
degradation. Under the National
SUMMARY:
VerDate Sep<11>2014
17:35 Dec 14, 2020
Jkt 253001
Environmental Policy Act, we invite
public comment on the draft
environmental assessment on the
proposed amended habitat conservation
plan and application.
DATES: To ensure consideration, written
comments must be received or
postmarked on or before January 14,
2021. We may not consider any
comments we receive after the closing
date in the final decision on this action.
ADDRESSES: Accessing Documents:
Internet: The dEA and HCP: You may
obtain electronic copies of these
documents at https://www.fws.gov/
southwest/es/AustinTexas/.
U.S. Mail: You may obtain the
documents by writing to the following
addresses. In your request for
documents, please reference Concordia
University HCP and ITP Amendment
(TE827597–4).
• DEA and HCP: A limited number of
CD–ROM and printed copies of the dEA
and HCP are available, by request, from
Mr. Jacob Ogdee; Austin Ecological
Services Field Office; U.S. Fish and
Wildlife Service; 10711 Burnet Road,
Suite 200; Austin, TX 78758; telephone
512–490–0057; fax 512–490–0974.
• ITP application: The ITP
application is available from the
Assistant Regional Director—Ecological
Services; U.S. Fish and Wildlife Service;
P.O. Box 1306, Room 6034;
Albuquerque, NM 87103; Attention:
Environmental Review Branch.
Submitting Comments: Regarding any
of the three documents available for
review, you may submit written
comments by one of the following
methods. In your comments, please
reference Concordia University HCP and
ITP Amendment (TE–827597–4).
Email: FW2_AUES_Consult@fws.gov.
U.S. Mail: Mr. Adam Zerrenner,
Austin Ecological Services Field Office,
10711 Burnet Road, Suite 200, Austin,
TX 78758–4460; telephone 512–490–
0057; fax 512–490–0974.
We request that you send comments
by only one of the methods described
above.
FOR FURTHER INFORMATION CONTACT:
Adam Zerrenner Field Supervisor, by
mail at U.S. Fish and Wildlife Service,
10711 Burnet Road, Suite 200, Austin,
TX 78758; via phone at 512–490–0057
or via the Federal Relay Service at 800–
877–8339.
SUPPLEMENTARY INFORMATION: We, the
U.S. Fish and Wildlife Service (Service),
make available a draft environmental
assessment (dEA) under the National
Environmental Policy Act for the
Habitat Conservation Plan for an
Endangered Species Act Section
10(a)(1)(B) Incidental Take Permit for
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
81215
the Golden-cheeked Warbler Previously
Associated with the 440-acre
Schlumberger Property to Include
Incidental Take of the Jollyville Plateau
Salamander Due to Activities
Associated with the Construction,
Operation, and Maintenance of
Concordia University Texas, in Travis
County, Texas. Concordia University
applied for an amendment to their
existing HCP and incidental take permit
(ITP) under the Endangered Species Act
(16 U.S.C. 1531 et seq.) that would add
authorization for incidental take of the
Jollyville Plateau salamander (Eurycea
tonkawae) to the already permitted
incidental take of golden-cheeked
warbler (Setophaga chrysoparia). The
dEA evaluates the impacts of, and
alternatives to, implementation of the
proposed HCP.
Background
Section 9 of the ESA (16 U.S.C. 1531
et seq.) and its implementing
regulations prohibit the ‘‘take’’ of
animal species listed as endangered or
threatened. Take is defined under the
ESA as to ‘‘harass, harm, pursue, hunt,
shoot, wound, kill, trap, capture, or
collect listed animal species, or to
attempt to engage in such conduct’’ (16
U.S.C. 1538). However, under section
10(a) of the ESA, we may issue permits
to authorize incidental take of listed
species. ‘‘Incidental take’’ is defined by
the ESA as take that is incidental to, and
not the purpose of, carrying out an
otherwise lawful activity. Regulations
governing such take of endangered and
threatened species, respectively, are
found in the Code of Federal
Regulations at 50 CFR 17.22 and 50 CFR
17.32.
Alternatives
Proposed Action
The proposed action involves the
issuance of an amended ITP by the
Service for the covered activities in the
permit area, under section 10(a)(1)(B) of
the ESA. The ITP would cover ‘‘take’’ of
the covered species associated with
construction, operation, and
maintenance of Concordia University
within the permit area. An application
for an ITP must include a HCP that
describes the conservation measures the
applicant has agreed to undertake to
minimize and mitigate for the impacts
of the proposed taking of covered
species to the maximum extent
practicable. The applicant will fully
implement the HCP if approved by the
Service. The terms of the HCP and ITP
will also ensure that incidental take will
not appreciably reduce the likelihood of
E:\FR\FM\15DEN1.SGM
15DEN1
]]>Agencies
[Federal Register Volume 85, Number 241 (Tuesday, December 15, 2020)]
[Notices]
[Pages 81214-81215]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-27547]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Advancing Translational Sciences; Notice of
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Center for
Advancing Translational Sciences Advisory Council.
The meeting will be open to the public as indicated below, viewing
virtually by WebEx. Individuals can register to view and access the
meeting by the links below:
January 14, 2021 WebEx: https://nih.webex.com/nih/onstage/g.php?MTID=efd5d81157ca86678111c546ced7a91fa.
January 15, 2021 WebEx: https://nih.webex.com/nih/onstage/g.php?MTID=eda63cdefa13a124ac49e7cffdac33aac.
1. Go to ``Event Status'' on the left-hand side of page, then click
``Register''. On the registration form, enter your information and then
click ``Submit'' to complete the required registration.
2. You will receive a personalized email with the live event link.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Center for Advancing Translational
Sciences Advisory Council.
Date: January 14-15, 2021.
Closed: January 14, 2021, 11:00 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, One Democracy Plaza, 9th
Floor, Conference Rooms 987/989, 6701 Democracy Boulevard, Bethesda,
MD 20892 (Virtual Meeting).
Open: January 14, 2021, 1:00 p.m. to 4:00 p.m.
Agenda: Report from the Institute Director and other staff.
Place: National Institutes of Health, One Democracy Plaza, 9th
Floor, Conference Rooms 987/989, 6701 Democracy Boulevard, Bethesda,
MD 20892 (Virtual Meeting).
Open: January 15, 2021, 1:00 p.m. to 5:00 p.m.
Agenda: To view and discuss Clearance of Concepts.
[[Page 81215]]
Place: National Institutes of Health, One Democracy Plaza, 9th
Floor, Conference Rooms 987/989, 6701 Democracy Boulevard, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Anna L. Ramsey-Ewing, Ph.D., Executive
Secretary, National Center for Advancing Translational Sciences, One
Democracy Plaza, Room 1072, Bethesda, MD 20892, (301) 435-0809,
[email protected].
Attendees and interested parties may submit questions and
comments through written Q&A during the meeting, and for 15 days
after the meeting, to [email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice no later than 15 days after the meeting. The
statement should include the name, address, telephone number and
when applicable, the business or professional affiliation of the
interested person.
(Catalogue of Federal Domestic Assistance Program Nos. 93.859,
Pharmacology, Physiology, and Biological Chemistry Research; 93.350,
B--Cooperative Agreements; 93.859, Biomedical Research and Research
Training, National Institutes of Health, HHS).
Dated: December 10, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-27547 Filed 12-14-20; 8:45 am]
BILLING CODE 4140-01-P
